SARCOMA, EWING
Clinical trials for SARCOMA, EWING explained in plain language.
Never miss a new study
Get alerted when new SARCOMA, EWING trials appear
Sign up with your email to follow new studies for SARCOMA, EWING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough bone cancer: drug combo trial launches
Disease control OngoingThis study tests whether adding the drug abemaciclib to standard chemotherapy can help people with Ewing's sarcoma that has returned or not responded to treatment. About 46 children and young adults will participate. The goal is to see if the combination slows tumor growth and im…
Matched conditions: SARCOMA, EWING
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for young cancer patients: experimental combo targets stubborn tumors
Disease control TerminatedThis study tests a new drug called PEN-866 combined with two standard chemotherapy drugs (vincristine and temozolomide) in people aged 12 to 39 whose solid tumors, including Ewing sarcoma and rhabdomyosarcoma, have come back or not responded to standard treatments. The goal is to…
Matched conditions: SARCOMA, EWING
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:01 UTC